DelveInsight’s, “Bladder Cancer Pipeline Insight 2025” report provides comprehensive insights about 80+ companies and 100+ pipeline drugs in the Bladder cancer pipeline landscape. It covers ...

Shares in US biotech Five Prime Therapeutics more than tripled after it reported promising trial results with stomach cancer drug candidate bemarituzumab, returning the stock to levels not seen ...

Amgen is to buy US biotech Five Prime Therapeutics for around $1.9 billion, adding a potential gastric cancer drug to its pipeline. The big pharma swooped in after the California biotech reported ...

Cargo was founded by two highly acclaimed cell-therapy researchers. The company raised over $500 million to develop ...

We came across a bullish thesis on CRISPR Therapeutics AG (CRSP ... could generate $1 billion in sales by 2026 and reach $3.5 ...

Prime Medicine and Beam Therapeutics had common origins in gene editing. Now they're both pursuing treatments for the same ...

We recently published a list of 10 Hot Biotech Stocks Under $5. In this article, we are going to take a look at where Compass Therapeutics, Inc. (NASDAQ:CMPX) stands against other hot biotech ...

Protagenic Therapeutics, Inc, a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound ...

During the last three months, 5 analysts shared their evaluations of Y-mAbs Therapeutics YMAB, revealing diverse outlooks from bullish to bearish. In the table below, you'll find a summary of ...

We recently published a list of 10 Hot Biotech Stocks Under $5. In this article, we are going to take a look at where Heron Therapeutics, Inc. (NASDAQ:HRTX) stands against other hot biotech stocks ...